Keep Your Feline Patients Protected

IMPORTANT SAFETY INFORMATION: NexGard^® COMBO (esafoxolaner, eprinomectin, and praziquantel topical solution) is for topical use only in cats. Use with caution in cats with a history of seizures or neurologic disorders. The most frequently reported adverse reactions include vomiting, application site reactions, lethargy, and anorexia. If ingested, hypersalivation may occur. Avoid direct contact with application site until visibly dry. For more information, click here for full prescribing information.

MPORTANT SAFETY INFORMATION: CENTRAGARD^® (eprinomectin and praziquantel transdermal solution) is for topical use only. Side effects may include emesis, anorexia, lethargy, and hair changes and skin reactions at the site of application. If ingested, hypersalivation, vomiting and lethargy may be observed. The safety of CENTRAGARD has not been tested in kittens less than 7 weeks of age or less than 1.8 lbs. For more information, please see full prescribing information.

Precautions: Do not administer orally. Cats may salivate excessively and vomit if CENTRAGARD is accidentally administered orally or is ingested through licking/grooming the application site. The safety of CENTRAGARD has not been tested in breeding, pregnant, or lactating cats.